Kidney transplantation in Icelandic patients, 2000-2019: are outcomes affected by low volume?
- PMID: 38993778
- PMCID: PMC11235228
- DOI: 10.3389/frtra.2024.1398444
Kidney transplantation in Icelandic patients, 2000-2019: are outcomes affected by low volume?
Abstract
Background: In Iceland, a small number of kidney transplants from living donors (LDs) are performed at Landspitali University Hospital (LUH) in Reykjavik, while deceased donor transplants have until recently invariably been carried out abroad. In this study, we evaluated the outcome of kidney transplantation in Icelandic patients.
Methods: This was a retrospective study that included all Icelandic residents who underwent kidney transplantation between 1 January 2000 and 31 December 2019. Data were obtained from the Icelandic End-Stage Kidney Disease Registry, medical records at LUH, and the Scandiatransplant database. The Chronic Kidney Disease Epidemiology Collaboration equation was used to calculate estimated glomerular filtration rate from serum creatinine for recipients and donors aged >18 years, and the modified Schwartz equation for those aged ≤18 years. Survival was estimated using the Kaplan-Meier method, and the log-rank test was employed for group comparisons.
Results: A total of 229 kidney transplants in 221 patients were performed during the 20-year period, of which 135 (58.9%) were from LDs. Transplants carried out at LUH were 118 (51.5%), of which 116 were from LDs. During a median follow-up of 7.4 years (range 0.1-20), 27 (12.2%) patients died, 20 (74%) of whom had a functioning graft. One-year patient survival was 99.1% [95% confidence interval (CI), 97.9-100], 5-year survival was 95.7% (95% CI, 92.7-98.7), and 10-year survival was 87.7% (95% CI, 82.4-93.4). Death-censored graft survival was 98.3% (95% CI, 96.6-100), 96.8% (95% CI, 94.4-99.2), and 89.2% (95% CI, 84.1-94.7) at 1, 5, and 10 years, respectively.
Conclusions: Patient and graft survival are comparable with those of large transplant centers, demonstrating the feasibility of running a quality kidney transplant program in a small nation in collaboration with a larger center abroad.
Keywords: deceased donor; graft function; graft survival; kidney graft; living donor; low-volume center.
© 2024 Palsson, Andresdottir, Jonsson, Jonsson, Hilmarsson, Indridason and Palsson.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
A2/A2B Deceased Donor Kidney Transplantation Using A2 Titers Improves Access to Kidney Transplantation: A Single-Center Study.Kidney Med. 2024 May 21;6(7):100843. doi: 10.1016/j.xkme.2024.100843. eCollection 2024 Jul. Kidney Med. 2024. PMID: 38947773 Free PMC article.
-
US deceased kidney transplantation: Estimated GFR, donor age and KDPI association with graft survival.EClinicalMedicine. 2021 Jun 23;37:100980. doi: 10.1016/j.eclinm.2021.100980. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34386752 Free PMC article.
-
Utilization and Outcomes of Single and Dual Kidney Transplants from Older Deceased Donors in the United Kingdom.Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1320-1329. doi: 10.2215/CJN.02060220. Epub 2020 Jul 20. Clin J Am Soc Nephrol. 2020. PMID: 32690721 Free PMC article.
-
The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation.Yonsei Med J. 2017 May;58(3):626-630. doi: 10.3349/ymj.2017.58.3.626. Yonsei Med J. 2017. PMID: 28332370 Free PMC article.
-
Living Donor Kidney Transplantation Improves Graft and Recipient Survival in Patients with Multiple Kidney Transplants.J Clin Med. 2020 Jul 5;9(7):2118. doi: 10.3390/jcm9072118. J Clin Med. 2020. PMID: 32635614 Free PMC article.
References
LinkOut - more resources
Full Text Sources